Aside from blaESBL, we detected significantly higher antibiotic resistance rates in nosocomial non-ST131 isolates compared with community non-ST131 isolates with the alarming emergence of carbapenemase, mcr, and fosA genes in the nosocomial setting representing a challenge for the treatment of these infections. This evidence concerns the gene NR3C2 and infection.